Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Uniqsis makes available plug and play reactor modules for flow chemistry
, /in Product News /by panglobalUniqsis is making flow chemistry accessible to everyone, while at the same time catering for multi-step and automated reactions sequences, through the availability of an expanding suite of affordable ‘plug and play’ reactor modules. Compatible with all Uniqsis coil reactors and with an operating temperature range of ambient to +300°C, the HotCoil reactor heating module […]
New glial cells discovered in the brain: Implications for brain repair
, /in E-News /by panglobalNeurons, nerve cells in the brain, are central players in brain function. However, a key role for glia, long considered support cells, is emerging. A research group at the University of Basel has now discovered two new types of glial cells in the brain, by unleashing adult stem cells from their quiescent state. These new […]
Thermo Fisher Scientific upgrades TSX Series ULT Freezers
, /in Product News /by Thermo Fisher CorporationThermo Fisher Scientific’s TSX Series Ultra- Low Temperature (ULT) Freezers have been fully upgraded to include additional functionality to provide research, pharmaceutical manufacturing, clinical, biorepository and industrial laboratories with safeguards to deliver environmentally sustainable protection of materials, such as vaccines, cell culture media, biologics and reagents.
Porvair Sciences introduces new kit for rapid extraction of total RNA
, /in Product News /by panglobalPorvair Sciences has launched new kit for rapid extraction of total RNA from a wide range of biological samples.
FDA approves aducanumab for treatment of Alzheimer’s
, /in E-News /by panglobalThe U.S. FDA has approved Aduhelm (aducanumab) developed by Biogen, Cambridge, Massachusetts, for the treatment of Alzheimer’s. Aduhelm was approved using the ‘accelerated approval pathway’.
Sphere Fluidics and ClexBio introduce CYTRIX Microfluidic Hydrogel Kit
, /in Product News /by panglobalSphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and ClexBio, a pioneer in solutions for tissue engineering and single-cell techniques, have launched a biocompatible CYTRIX Microfluidic Hydrogel Kit.
Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards
, /in E-News /by panglobalThe Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at the OBN 2020 Awards. The award recognises the company’s outstanding contribution to the fight against COVID-19.
BioChromato develops optimized tube plate for enzyme studies
, /in Product News /by panglobalBioChromato has developed an enzyme assay product – the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies.
Transgene strengthen global IP protection for its novel Invir.IO oncolytic viruses encoding ICIs
, /in E-News /by panglobalTransgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, has received a patent from the Japan Patent Office for their oncolytic virus (OV) backbone VVcopTK-RR- that encodes one or more immune checkpoint inhibitors (ICIs).
Lunaphore appoints Matthias Weber, former President of Leica Biosystems, to Board of Directors
, /in E-News /by panglobalLunaphore Technologies, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, has appointed Matthias Weber, former President of Leica Biosystems, to its Board of Directors. Weber has been appointed to represent the interests of strategic investor PHC Holdings Corporation (PHCHD), who previously invested in Lunaphore through a Series C financing round in 2020.